The Centers for Disease Control and Prevention (CDC) is soliciting nominations for membership on the Clinical Laboratory Improvement Advisory Committee (CLIAC). This committee provides scientific and technical advice and guidance to the Secretary, Department of Health and Human Services (HHS); the Assistant Secretary for Health, HHS; the Director, CDC, The Commissioner, Food and Drug Administration; and the Administrator for Medicare & Medicaid Services. The advice and guidance pertain to general issues related to improvement in clinical laboratory quality and laboratory medicine.
Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to accomplishing CLIAC’s objectives. Nominees will be selected by the HHS Secretary or designee from authorities knowledgeable across the fields of microbiology (including bacteriology, mycobacteriology, mycology, parasitology, and virology), immunology (including histocompatibility), chemistry, hematology, pathology (including histopathology and cytology), or genetic testing (including cytogenetics); representatives from the fields of medical technology, public health, and clinical practice; and consumer representatives. The nominations will close on September 15, 2015. For additional information, please refer to the Federal Register Announcement.